Literature DB >> 27076541

Sleep-related melatonin use in healthy children.

Irvin Janjua, Ran D Goldman.   

Abstract

QUESTION: A mother brought her 12-year-old son into my office because she is concerned that he has difficulty falling asleep almost every night. Her job involves shift work and she uses melatonin herself to help her fall asleep. She asked if her son could take melatonin. What are the recommendations and considerations for using melatonin in otherwise healthy children and adolescents? ANSWER: Insomnia is reported in up to a quarter of healthy children and in three-quarters of children with neurodevelopmental and psychiatric conditions, resulting in negative consequences. For children with delayed sleep phase syndrome, melatonin can be a useful treatment together with insomnia evaluation and regular follow-up. For children with otherwise undiagnosed insomnia and healthy sleep hygiene, melatonin use should be considered. While melatonin seems to be safe, there is a lack of evidence for its routine use among healthy children. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27076541      PMCID: PMC4830653     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  14 in total

Review 1.  Pediatric sleep pharmacology.

Authors:  Rafael Pelayo; Kin Yuen
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2012-10

2.  Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial.

Authors:  M G Smits; E E Nagtegaal; J van der Heijden; A M Coenen; G A Kerkhof
Journal:  J Child Neurol       Date:  2001-02       Impact factor: 1.987

Review 3.  Excessive sleepiness in adolescents and young adults: causes, consequences, and treatment strategies.

Authors:  Richard P Millman
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

Review 4.  Pharmacologic treatment of pediatric insomnia.

Authors:  Judith A Owens; Sricharan Moturi
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2009-10

5.  Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians.

Authors:  Judith A Owens; Carol L Rosen; Jodi A Mindell
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

Review 6.  Developing circadian rhythmicity in infants.

Authors:  Scott A Rivkees
Journal:  Pediatrics       Date:  2003-08       Impact factor: 7.124

7.  Melatonin for the management of sleep disorders in children and adolescents.

Authors:  Carl Cummings
Journal:  Paediatr Child Health       Date:  2012-06       Impact factor: 2.253

8.  Increased nocturnal melatonin secretion in male patients with hypogonadotropic hypogonadism and delayed puberty.

Authors:  R Luboshitzky; S Lavi; I Thuma; P Lavie
Journal:  J Clin Endocrinol Metab       Date:  1995-07       Impact factor: 5.958

9.  Sleep duration from ages 1 to 10 years: variability and stability in comparison with growth.

Authors:  Oskar G Jenni; Luciano Molinari; Jon A Caflisch; Remo H Largo
Journal:  Pediatrics       Date:  2007-10       Impact factor: 7.124

Review 10.  Pediatric sleep pharmacology.

Authors:  Rafael Pelayo; Michael Dubik
Journal:  Semin Pediatr Neurol       Date:  2008-06       Impact factor: 1.636

View more
  5 in total

Review 1.  Management of sleep disorders among children and adolescents with neurodevelopmental disorders: A practical guide for clinicians.

Authors:  Michael O Ogundele; Chinnaiah Yemula
Journal:  World J Clin Pediatr       Date:  2022-03-15

2.  Trends in Nutrient- and Non-Nutrient-Containing Dietary Supplement Use among US Children from 1999 to 2016.

Authors:  Anita A Panjwani; Alexandra E Cowan; Shinyoung Jun; Regan L Bailey
Journal:  J Pediatr       Date:  2020-12-17       Impact factor: 4.406

3.  Prophylaxis with melatonin for primary stabbing headache in pediatrics: a case report.

Authors:  Mauricio Bermúdez Salazar; Christian Andrés Rojas Cerón; Ronald Santiago Arana Muñoz
Journal:  Colomb Med (Cali)       Date:  2018-09-30

Review 4.  Efficacy and safety of supplemental melatonin for delayed sleep-wake phase disorder in children: an overview.

Authors:  David Mantle; Marcel Smits; Myrthe Boss; Irene Miedema; Inge van Geijlswijk
Journal:  Sleep Med X       Date:  2020-08-19

5.  Hyperphosphorylation of Tau Due to the Interference of Protein Phosphatase Methylesterase-1 Overexpression by MiR-125b-5p in Melatonin Receptor Knockout Mice.

Authors:  Han Zhao; Lingyan Feng; Wei Zhong; Hongyan Zhen; Qingjia Chi; Xiang Wang
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.